NanoViricides (NNVC)

• Market cap: $29.9M
• 1 day: -0.76%
• 5 days: -3.7%
• 1 month: -13.91%
• 3 months: 36.84%
• 6 months: 9.24%
• Year to date: 7.44%
• 1 year: -7.14%
• 5 years: -72.04%
• 10 years: -95.81%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Employees: 7